Neurology Contract Research Organization Market
Neurology Contract Research Organization Market Study by Clinical, Data Management, Drug Safety, Medical & Scientific Writing, Pharmacology & Toxicology, and Others from 2024 to 2034
Analysis of Neurology Contract Research Organization Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Neurology Contract Research Organization Market Overview (2024 to 2034)
The global neurology contract research organization market is expected to be worth US$ 5,923.9 million in 2024. The market is anticipated to expand at a CAGR of 6.8% from 2024 to 2034. The market is predicted to surpass US$ 11,405.8 million in 2034.
The increasing prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. As the population ages, the demand for treatments and therapies for these conditions is expected to rise, leading to more clinical trials and research studies.
There has been a shift towards outsourcing clinical trials to specialized CROs, which provide expertise and resources that may not be available in-house. This allows pharmaceutical companies to focus on their core competencies and reduce costs associated with clinical trial management. Furthermore, developing new and innovative treatments for neurological disorders contributes to the growth of the neurology contract research organization market.
As more therapies are developed, there is a need for clinical trials to test their safety and efficacy, which in turn drives demand for CRO services. Another factor contributing to the growth of the neurology contract research organization industry is the increasing complexity of clinical trials.
With the rise of precision medicine and personalized therapies, clinical trials are becoming more complex and require specialized expertise. Neurology contract research organizations are well-equipped to handle this complexity and provide various services, including study design, site selection, patient recruitment, data management, and regulatory compliance.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 5,923.9 million |
| Forecasted Market Value (2034F) | US$ 11,405.8 million |
| Global Market Growth Rate (2024 to 2034) | 6.8% CAGR |
| Clinical Services Growth Rate (2024 to 2034) | 8.8% CAGR |
| North America Market Share (2024) | 43.9% |
| East Asia Market Share (2024) | 20.0% |
| Key Companies Profiled | Charles River Laboratories; IQVIA Inc.; Syneos Health; Parexel International Corporation; ICON Plc.; Medpace; Laboratory Corporation of America Holdings; Axon CRO; Thermo Fisher Scientific Inc. (PPD Inc.); CTI Clinical Trial & Consulting; Pharmaron Beijing Co., Ltd; Neuroservices-Alliance; QPS Neuropharmacology; MD Biosciences |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Factors Have Contributed to a Rise in Global Demand for the Neurology contract research organization?
“The Growing Adoption of Outsourcing by Pharmaceutical and Biotechnology Companies is Expected to Drive the Growth of the Market”
The neurology contract research organization market is expected to witness significant growth in the coming years due to the rapidly increasing adoption of outsourcing by pharmaceutical and biotechnology companies. This trend is driven by the need to reduce costs, accelerate drug development timelines, and increase efficiency.
Outsourcing to CROs allows companies to access specialized expertise, technologies, and infrastructure that may not be available in-house, enabling them to focus on their core competencies.
The demand for neurology CRO services is also expected to be driven by the growing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. These conditions require extensive clinical research to develop effective treatments, which are expected to be facilitated by CROs.
In addition, the increasing focus on precision medicine and personalized therapies is expected to create new opportunities for neurology CROs. These therapies require a deep understanding of patient populations and disease mechanisms, which is likely to be achieved through advanced analytics and data science capabilities offered by CROs.
“The Rising Concerns Regarding Neurological Disorders is Projected to Create Attractive Prospects for Neurology Contract Research Organizations”
Neurological disorders are a growing concern worldwide, with a significant increase in the number of cases reported in recent years. This has led to a surge in demand for research and development activities to find effective treatments and therapies for these conditions. As a result, the market for Neurology Contract Research Organizations (CROs) is expected to witness significant growth in the coming years.
These organizations provide various services, including clinical trial management, data management, biostatistics, regulatory affairs, and medical writing. With the rising prevalence of neurological disorders, the demand for these services is projected to increase, thus driving the growth of the neurology contract research organization market.
Which Factor is Impeding the Growth of Neurology Contract Research Organization Demand?
“The Lack of Highly Skilled Professionals in the Sector is expected to hamper the Market Growth for the Forecast Period.”
The neurology contract research organization market is expected to face challenges in the forecast period due to the lack of highly skilled professionals in the field. This shortage of qualified professionals is expected to hamper the market's growth as it may lead to a delay in the completion of clinical trials and an increase in the cost of research activities.
The neurology contract research organization industry is highly specialized and requires professionals with expertise in neurology, clinical research, and data analysis. The shortage of these professionals may lead to a slower pace of innovation and research in the field of neurology.
This, in turn, may impact the development of new drugs and treatments for neurological disorders, significantly impacting patient care and outcomes. Therefore, it is essential to address this shortage of skilled professionals to ensure the growth and progress of the neurology contract research organization industry in the future.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
North America is estimated to account for 43.9% of the global market share in 2024. From 2024 to 2034, the region's market is expected to rise at a moderate CAGR of 5.4%, with a share of 38.7%.
In 2024, East Asia's share is predicted to be 20.0%. During the projection period, East Asia's market is expected to grow at a moderate 7.0% CAGR, with the region retaining 20.4% of the market share by the end.
What Factors Influence the Continued Growth of the United States Neurology Contract Research Organization?
“Rising Outsourcing Drug Discovery and Development Processes in the United States are Likely to Fuel Market Growth Throughout the Projection Period.”
The value of the neurology contract research organization industry in the United States for 2024 is estimated to be US$ 2,126 million. Over the forecast period, the market is expected to register an encouraging CAGR of 5.7% in the country, reaching a value of US$ 3,692 million by 2034.
Outsourcing drug discovery and development processes is expected to drive the growth of the neurology contract research organization market in the United States. These include the increasing prevalence of neurological disorders such as Alzheimer's, Parkinson's, and multiple sclerosis, as well as the growing demand for personalized medicine and targeted therapies.
Furthermore, a well-established healthcare infrastructure, a favorable regulatory environment, and a large pool of patients for clinical trials also contribute to the growth of the CRO market in the United States.
Why is China Recognized as a Major Market for Neurology contract research organizations?
“Increasing incidences of neurological disorders in China”
China has witnessed a significant increase in the incidence of neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis, among others, in recent years. According to a report by the National Health Commission of China, over 300 million people in the country suffer from neurological disorders.
This has led to a growing demand for effective treatments and therapies, which has resulted in an increased need for contract research organizations (CROs) specializing in neurology.
The Chinese government has been actively investing in the healthcare sector, including neurological research, which has created a favorable environment for the growth of the neurology contract research organization industry in China. The government has introduced various policies and initiatives to encourage research and development in the neurology field, attracting several local and international players to the market.
Category-wise Insights
Based on service type, the clinical services segment is expected to account for 30.6% of the market share in 2024.
Why Do Clinical Services Dominate the Market for Neurology Contract Research Organizations?
“Increasing Need for Temperature Control Options”
The clinical services segment is expected to contribute 30.6% share by product type in 2024. The clinical services are anticipated to witness a rise in demand for next-generation centrifuges at a CAGR of 8.8% through 2034.
The clinical services segment in the neurology contract research organization market involves various services related to clinical trials, including study design, site selection, patient recruitment, trial management, data management, and statistical analysis. With the increasing number of clinical trials being conducted across regions, the demand for clinical services offered by CROs is also growing, particularly in neurology.
Neurology contract research organizations offer clinical services, from early-phase development to post-marketing studies. These services help pharmaceutical and biotech companies conduct clinical trials more efficiently, focusing on safety, quality, and regulatory compliance.
The clinical services segment is expected to grow in the coming years, driven by the increasing demand for specialized expertise and the need for faster, more cost-effective drug development.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
The key players in the neurology contract research organization market focus on expanding their geographic presence, strengthening their service offerings, and improving their operational efficiency to gain a competitive edge.
These companies invest heavily in research and development to develop innovative solutions and technologies to meet the growing demand for neurology clinical trials. They are also partnering with other players in the market to expand their service offerings and cater to a larger customer base.
Some of the prominent companies in the market are Charles River Laboratories, IQVIA Inc., Syneos Health, Parexel International Corporation, ICON Plc., Medpace, Laboratory Corporation of America Holdings
In 2021, Syneos Health, a leading technology-enabled clinical trial recruitment and retention services supplier, announced they acquired StudyKIK. This acquisition would enable Syneos Health to provide more innovative, insight-driven solutions.
Segmentation of Next-Generation Centrifuge Market Research
-
By Service Type:
- Clinical Services
- Data Management Services
- Drug safety
- Medical and Scientific Writing
- Regulatory Affairs
- Pharmacology & Toxicology
- Quality and Compliance
-
By Study Type:
- Neuroscience focused
- Neurology focused
-
By Indication:
- Alzheimer's Disease
- Brain Tumors
- Epilepsy
- Headaches
- Schizophrenia
- Depressive disorder
- Multiple Sclerosis
- Muscular Dystrophy
- PARKINSON'S DISEASE
- PMA
- Stroke
- Psychiatry
- ASD
- CALD
- Sleep Apnea
-
By End User:
- Pharmaceutical & Biopharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Academic and Research Institutes
-
By Region:
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service
- 5.1. Clinical Services
- 5.1.1. Early Phase/Phase I Development
- 5.1.2. Phase IIB-III Clinical Trials
- 5.1.3. Phase IIIB-Phase IV Clinical Trials
- 5.1.4. 510(k) Clinical Studies
- 5.1.5. IDE Clinical Studies
- 5.1.6. IND Clinical Studies
- 5.1.7. PMA Clinical Studies
- 5.1.8. De Novo Clinical Studies
- 5.1.9. Retrospective Clinical Studies
- 5.2. Data Management Services
- 5.2.1. Clinical Database Selection
- 5.2.2. Clinical Study Planning and Clinical Protocol Development
- 5.2.3. Clinical Site Budget Development
- 5.2.4. Data Management (DM) and Biostatistics (BS)
- 5.3. Drug Safety
- 5.4. Medical and Scientific Writing
- 5.5. Regulatory Affairs
- 5.6. Pharmacology and Toxicology
- 5.7. Quality and Compliance
- 5.1. Clinical Services
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Study
- 6.1. Neuroscience focused
- 6.2. Neurology focused
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
- 7.1. Alzheimer's Disease
- 7.2. Brain Tumors
- 7.3. Epilepsy & Seizures
- 7.4. Headaches
- 7.5. Schizophrenia
- 7.6. Depressive Disorder
- 7.7. Multiple Sclerosis (MS)
- 7.8. Muscular Dystrophy
- 7.9. Parkinson's Disease
- 7.10. Progressive Muscular Atrophy (PMA)
- 7.11. Stroke
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
- 8.1. Pharmaceutical & Biopharmaceutical Companies
- 8.2. Biopharmaceutical Companies
- 8.3. Medical Device Companies
- 8.4. Academic and Research Institutes
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. South Asia and Pacific
- 9.6. East Asia
- 9.7. Middle East and Africa
- 10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 17. Key Countries Market Analysis
- 18. Market Structure Analysis
- 19. Competition Analysis
- 19.1. Charles River Laboratories
- 19.2. Laboratory Corporation of America Holdings
- 19.3. IQVIA Inc.
- 19.4. Syneos Health
- 19.5. Parexel International Corporation
- 19.6. ICON Plc.
- 19.7. Medpace
- 19.8. Axon CRO
- 19.9. Thermo Fisher Scientific Inc. (PPD Inc.)
- 19.10. CTI Clinical Trial & Consulting
- 20. Assumptions & Acronyms Used
- 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Study, 2019 to 2034
Table 4: Global Market Value (US$ Million) Forecast by Indication , 2019 to 2034
Table 5: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 6: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 8: North America Market Value (US$ Million) Forecast by Study, 2019 to 2034
Table 9: North America Market Value (US$ Million) Forecast by Indication , 2019 to 2034
Table 10: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 12: Latin America Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 13: Latin America Market Value (US$ Million) Forecast by Study, 2019 to 2034
Table 14: Latin America Market Value (US$ Million) Forecast by Indication , 2019 to 2034
Table 15: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 16: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 17: Western Europe Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 18: Western Europe Market Value (US$ Million) Forecast by Study, 2019 to 2034
Table 19: Western Europe Market Value (US$ Million) Forecast by Indication , 2019 to 2034
Table 20: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 21: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 22: Eastern Europe Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 23: Eastern Europe Market Value (US$ Million) Forecast by Study, 2019 to 2034
Table 24: Eastern Europe Market Value (US$ Million) Forecast by Indication , 2019 to 2034
Table 25: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 26: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 27: South Asia and Pacific Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 28: South Asia and Pacific Market Value (US$ Million) Forecast by Study, 2019 to 2034
Table 29: South Asia and Pacific Market Value (US$ Million) Forecast by Indication , 2019 to 2034
Table 30: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 31: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 32: East Asia Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 33: East Asia Market Value (US$ Million) Forecast by Study, 2019 to 2034
Table 34: East Asia Market Value (US$ Million) Forecast by Indication , 2019 to 2034
Table 35: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 36: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 37: Middle East and Africa Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 38: Middle East and Africa Market Value (US$ Million) Forecast by Study, 2019 to 2034
Table 39: Middle East and Africa Market Value (US$ Million) Forecast by Indication , 2019 to 2034
Table 40: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Million) by Service, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Study, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Indication , 2024 to 2034
Figure 4: Global Market Value (US$ Million) by End User, 2024 to 2034
Figure 5: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 6: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 9: Global Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 10: Global Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 11: Global Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 12: Global Market Value (US$ Million) Analysis by Study, 2019 to 2034
Figure 13: Global Market Value Share (%) and BPS Analysis by Study, 2024 to 2034
Figure 14: Global Market Y-o-Y Growth (%) Projections by Study, 2024 to 2034
Figure 15: Global Market Value (US$ Million) Analysis by Indication , 2019 to 2034
Figure 16: Global Market Value Share (%) and BPS Analysis by Indication , 2024 to 2034
Figure 17: Global Market Y-o-Y Growth (%) Projections by Indication , 2024 to 2034
Figure 18: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 21: Global Market Attractiveness by Service, 2024 to 2034
Figure 22: Global Market Attractiveness by Study, 2024 to 2034
Figure 23: Global Market Attractiveness by Indication , 2024 to 2034
Figure 24: Global Market Attractiveness by End User, 2024 to 2034
Figure 25: Global Market Attractiveness by Region, 2024 to 2034
Figure 26: North America Market Value (US$ Million) by Service, 2024 to 2034
Figure 27: North America Market Value (US$ Million) by Study, 2024 to 2034
Figure 28: North America Market Value (US$ Million) by Indication , 2024 to 2034
Figure 29: North America Market Value (US$ Million) by End User, 2024 to 2034
Figure 30: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 31: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 34: North America Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 37: North America Market Value (US$ Million) Analysis by Study, 2019 to 2034
Figure 38: North America Market Value Share (%) and BPS Analysis by Study, 2024 to 2034
Figure 39: North America Market Y-o-Y Growth (%) Projections by Study, 2024 to 2034
Figure 40: North America Market Value (US$ Million) Analysis by Indication , 2019 to 2034
Figure 41: North America Market Value Share (%) and BPS Analysis by Indication , 2024 to 2034
Figure 42: North America Market Y-o-Y Growth (%) Projections by Indication , 2024 to 2034
Figure 43: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 46: North America Market Attractiveness by Service, 2024 to 2034
Figure 47: North America Market Attractiveness by Study, 2024 to 2034
Figure 48: North America Market Attractiveness by Indication , 2024 to 2034
Figure 49: North America Market Attractiveness by End User, 2024 to 2034
Figure 50: North America Market Attractiveness by Country, 2024 to 2034
Figure 51: Latin America Market Value (US$ Million) by Service, 2024 to 2034
Figure 52: Latin America Market Value (US$ Million) by Study, 2024 to 2034
Figure 53: Latin America Market Value (US$ Million) by Indication , 2024 to 2034
Figure 54: Latin America Market Value (US$ Million) by End User, 2024 to 2034
Figure 55: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 59: Latin America Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 62: Latin America Market Value (US$ Million) Analysis by Study, 2019 to 2034
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Study, 2024 to 2034
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Study, 2024 to 2034
Figure 65: Latin America Market Value (US$ Million) Analysis by Indication , 2019 to 2034
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Indication , 2024 to 2034
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Indication , 2024 to 2034
Figure 68: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 71: Latin America Market Attractiveness by Service, 2024 to 2034
Figure 72: Latin America Market Attractiveness by Study, 2024 to 2034
Figure 73: Latin America Market Attractiveness by Indication , 2024 to 2034
Figure 74: Latin America Market Attractiveness by End User, 2024 to 2034
Figure 75: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 76: Western Europe Market Value (US$ Million) by Service, 2024 to 2034
Figure 77: Western Europe Market Value (US$ Million) by Study, 2024 to 2034
Figure 78: Western Europe Market Value (US$ Million) by Indication , 2024 to 2034
Figure 79: Western Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 80: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 81: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 82: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 83: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 84: Western Europe Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 85: Western Europe Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 86: Western Europe Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 87: Western Europe Market Value (US$ Million) Analysis by Study, 2019 to 2034
Figure 88: Western Europe Market Value Share (%) and BPS Analysis by Study, 2024 to 2034
Figure 89: Western Europe Market Y-o-Y Growth (%) Projections by Study, 2024 to 2034
Figure 90: Western Europe Market Value (US$ Million) Analysis by Indication , 2019 to 2034
Figure 91: Western Europe Market Value Share (%) and BPS Analysis by Indication , 2024 to 2034
Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by Indication , 2024 to 2034
Figure 93: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 94: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 95: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 96: Western Europe Market Attractiveness by Service, 2024 to 2034
Figure 97: Western Europe Market Attractiveness by Study, 2024 to 2034
Figure 98: Western Europe Market Attractiveness by Indication , 2024 to 2034
Figure 99: Western Europe Market Attractiveness by End User, 2024 to 2034
Figure 100: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 101: Eastern Europe Market Value (US$ Million) by Service, 2024 to 2034
Figure 102: Eastern Europe Market Value (US$ Million) by Study, 2024 to 2034
Figure 103: Eastern Europe Market Value (US$ Million) by Indication , 2024 to 2034
Figure 104: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 105: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 106: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 110: Eastern Europe Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 111: Eastern Europe Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 112: Eastern Europe Market Value (US$ Million) Analysis by Study, 2019 to 2034
Figure 113: Eastern Europe Market Value Share (%) and BPS Analysis by Study, 2024 to 2034
Figure 114: Eastern Europe Market Y-o-Y Growth (%) Projections by Study, 2024 to 2034
Figure 115: Eastern Europe Market Value (US$ Million) Analysis by Indication , 2019 to 2034
Figure 116: Eastern Europe Market Value Share (%) and BPS Analysis by Indication , 2024 to 2034
Figure 117: Eastern Europe Market Y-o-Y Growth (%) Projections by Indication , 2024 to 2034
Figure 118: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 119: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 120: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 121: Eastern Europe Market Attractiveness by Service, 2024 to 2034
Figure 122: Eastern Europe Market Attractiveness by Study, 2024 to 2034
Figure 123: Eastern Europe Market Attractiveness by Indication , 2024 to 2034
Figure 124: Eastern Europe Market Attractiveness by End User, 2024 to 2034
Figure 125: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 126: South Asia and Pacific Market Value (US$ Million) by Service, 2024 to 2034
Figure 127: South Asia and Pacific Market Value (US$ Million) by Study, 2024 to 2034
Figure 128: South Asia and Pacific Market Value (US$ Million) by Indication , 2024 to 2034
Figure 129: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034
Figure 130: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 131: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 132: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 133: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 134: South Asia and Pacific Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by Study, 2019 to 2034
Figure 138: South Asia and Pacific Market Value Share (%) and BPS Analysis by Study, 2024 to 2034
Figure 139: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Study, 2024 to 2034
Figure 140: South Asia and Pacific Market Value (US$ Million) Analysis by Indication , 2019 to 2034
Figure 141: South Asia and Pacific Market Value Share (%) and BPS Analysis by Indication , 2024 to 2034
Figure 142: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Indication , 2024 to 2034
Figure 143: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 144: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 145: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 146: South Asia and Pacific Market Attractiveness by Service, 2024 to 2034
Figure 147: South Asia and Pacific Market Attractiveness by Study, 2024 to 2034
Figure 148: South Asia and Pacific Market Attractiveness by Indication , 2024 to 2034
Figure 149: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034
Figure 150: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 151: East Asia Market Value (US$ Million) by Service, 2024 to 2034
Figure 152: East Asia Market Value (US$ Million) by Study, 2024 to 2034
Figure 153: East Asia Market Value (US$ Million) by Indication , 2024 to 2034
Figure 154: East Asia Market Value (US$ Million) by End User, 2024 to 2034
Figure 155: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 156: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 157: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 158: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 159: East Asia Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 160: East Asia Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 161: East Asia Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 162: East Asia Market Value (US$ Million) Analysis by Study, 2019 to 2034
Figure 163: East Asia Market Value Share (%) and BPS Analysis by Study, 2024 to 2034
Figure 164: East Asia Market Y-o-Y Growth (%) Projections by Study, 2024 to 2034
Figure 165: East Asia Market Value (US$ Million) Analysis by Indication , 2019 to 2034
Figure 166: East Asia Market Value Share (%) and BPS Analysis by Indication , 2024 to 2034
Figure 167: East Asia Market Y-o-Y Growth (%) Projections by Indication , 2024 to 2034
Figure 168: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 169: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 170: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 171: East Asia Market Attractiveness by Service, 2024 to 2034
Figure 172: East Asia Market Attractiveness by Study, 2024 to 2034
Figure 173: East Asia Market Attractiveness by Indication , 2024 to 2034
Figure 174: East Asia Market Attractiveness by End User, 2024 to 2034
Figure 175: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 176: Middle East and Africa Market Value (US$ Million) by Service, 2024 to 2034
Figure 177: Middle East and Africa Market Value (US$ Million) by Study, 2024 to 2034
Figure 178: Middle East and Africa Market Value (US$ Million) by Indication , 2024 to 2034
Figure 179: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034
Figure 180: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 182: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 183: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 184: Middle East and Africa Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 185: Middle East and Africa Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 186: Middle East and Africa Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 187: Middle East and Africa Market Value (US$ Million) Analysis by Study, 2019 to 2034
Figure 188: Middle East and Africa Market Value Share (%) and BPS Analysis by Study, 2024 to 2034
Figure 189: Middle East and Africa Market Y-o-Y Growth (%) Projections by Study, 2024 to 2034
Figure 190: Middle East and Africa Market Value (US$ Million) Analysis by Indication , 2019 to 2034
Figure 191: Middle East and Africa Market Value Share (%) and BPS Analysis by Indication , 2024 to 2034
Figure 192: Middle East and Africa Market Y-o-Y Growth (%) Projections by Indication , 2024 to 2034
Figure 193: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 194: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 195: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 196: Middle East and Africa Market Attractiveness by Service, 2024 to 2034
Figure 197: Middle East and Africa Market Attractiveness by Study, 2024 to 2034
Figure 198: Middle East and Africa Market Attractiveness by Indication , 2024 to 2034
Figure 199: Middle East and Africa Market Attractiveness by End User, 2024 to 2034
Figure 200: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the Market Outlook for the Neurology Contract Research Organization Market?
The neurology contract research organization's sales outlook is likely to be valued at US$ 5,923.9 million in 2024
Which is the Leading Service Type in the Neurology Contract Research Organization Market?
The clinical services segment is the leading product type in the market, with an expected market share of 30.6% in 2024.
How fast is the North America Market Expected to Grow?
The North America neurology contract research organization market is forecasted to expand at a CAGR of 5.4% through 2034
What is the Market Forecast for Neurology Contract Research Organization over the Next Decade?
The neurology contract research organization industry is projected to reach US$ 11,405.8 million by 2034.
Neurology Contract Research Organization Market